Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CapComm Partners is an investor relations consulting practice founded by Peter DeNardo in 2020, based in the San Francisco Bay Area. The firm provides outsourced senior-level investor relations support to pre-IPO and publicly traded companies, including those in the biotech, healthcare, technology, and other sectors. CapComm Partners differentiates itself by offering direct access to seasoned practitioners for clients, rather than junior staff, and aims to help management teams effectively communicate with and build relationships with Wall Street investors and analysts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CapComm Partners.